Cancer diagnostics market is expected to reach USD 232.7 billion by 2025 : Grand View Research, Inc.

The global cancer diagnostics market is expected to reach USD 232.7 billion by 2025, according to a new report by Grand View Research, Inc. Continual introduction of innovative products coupled with increasing need for early diagnosis of the disease is the prime factor driving the market growth. In addition, rapid growth of the sector is attributed to the penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering the demand for these screening tests and imaging modalities that are used for monitoring disease progression.

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early diagnosis of the disease. In addition, cancer research organizations along with public and private entities are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease way before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility of their products. For instance, Illumina, Inc. launched a new venture named GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than $100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.

Access Full research report on cancer diagnostics market analysis:
http://www.grandviewresearch.com/industry-analysis/cancer-diagnostics-market

Further Key Findings from the Study Suggest:

·         Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of the imaging systems space. Thus, the segment is expected to grow at the fastest CAGR at over 8.0% during the forecast period.

·         The breast cancer segment, among other application segments, accounted for the largest share due to the high incidence rate of breast cancer triggering the need for its early diagnosis.

·         In 2016, North America dominated the global space with the largest revenue share of more than 41%. Focused research efforts in oncology for the development of early tumor detection tools coupled with grants from government healthcare agencies are contributing to a strong medical ecosystem to fight cancer in this region.

·         Asia Pacific is expected to emerge as the fastest growing region during the forecast period. The growing patient pool in India, China, and Japan; due to the support in diagnostic process at comparatively lower prices; and a favorable regulatory framework are some of the factors boosting the market growth in this region.

·         Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd and Siemens Healthcare GmbH. Other prominent players operating in the market include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; .and Hologic, Inc.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the cancer diagnostics market by screening type, application, and region:

Cancer Diagnostics Screening Type Outlook (Revenue, USD Billion; 2014 - 2025)

·         Laboratory Tests

·         Genetic Tests

·         Imaging

·         Endoscopy

·         Biopsy

·         Others (barium enema)

Cancer Diagnostics Application Outlook (Revenue, USD Billion; 2014 - 2025)

·         Breast Cancer

·         Colorectal Cancer

·         Cervical Cancer

·         Lung Cancer

·         Prostate Cancer

·         Skin Cancer

·         Blood Cancer

·         Kidney Cancer

·         Liver Cancer

·         Pancreatic Cancer

·         Ovarian Cancer

·         Others

Cancer Diagnostics Regional Outlook (Revenue, USD Billion; 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    UK

·         Asia Pacific

o    China

o    Japan

o    India

·         Latin America

o    Mexico

o    Brazil

·         MEA

o    South Africa

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-cancer-diagnostics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: https://www.grandviewresearch.com/

Hair care Market expected to Trigger USD 211.1 billion by 2025 : Grand View Research, Inc.

The global hair care market is expected to reach USD 211.1 billion by 2025, according to a new report by Grand View Research, Inc. The increasing demand for hair color products, owing to the growing aging population base and increasing air pollution, are the major factors contributing toward significant market growth.

Growing trend in fashion industry and rising hair-related problems coupled with technological innovation in product manufacturing are one of the high impact rendering factors contributing to the demand of products and services, which thus propel the growth of the market. In addition, high penetration of salon services across the globe along with increasing demand for professional products, and changing grooming pattern especially among male consumers are another drivers accelerating the market growth.

Moreover, the increasing migration of rural population to metropolitan areas and rising expenditure on beauty and personal care products are anticipated to accelerate the market growth. Thus, resulting in the introduction of modified products sustaining the various needs of the consumers based on different cultures, regions and hair types.

Access Full research report on hair care market analysis:
https://www.grandviewresearch.com/industry-analysis/hair-care-market

Further Key Findings From the Report:

·         Services held the largest market share owing to the growing popularity of hair extensions in countries such as the UK, and the U.S., and the inclination towards enhanced appearance coupled with growing population base.

·         Shampoo held the largest share in the product segment due to rising consumer awareness on the benefits of organic and natural shampoo. The increasing air pollution coupled with high adoption rate of shampoo in daily use is attributed to the largest market share.

·         Hair color is expected to witness fastest growing product over the forecast period owing to the changing fashion trend. The increasing penetration of national and international salons in tier II and tier III cities in Asia Pacific, EMEA and North America region and rising product visibility across multi-retail outlets contribute to the fastest growth of the product.

·         U.S. dominated the hair care market owing to the presence of large multinational companies focusing on providing superior quality hair care products such as styling products, conditioner, color and shampoo.

·         India is expected to be the fastest growing country with a CAGR of 9.73% due to the presence of wide range of hair oil products.

·         Some of the key players are L’Oreal, Hindustan Unilever Ltd., P&G, Kao Corporation, Marico Limited, Aveda Corporation, Henkel Corporation, Combe Incorporated, Johnson & Johnson, and Avon.

·         Most of the companies are engaged in adopting strategies such as mergers and acquisition, collaborations, and new product development to increase their market share. For instance, in September 2017, L’Oréal and Natura Cosmeticos SA signed an agreement for the sale of The Body Shop to Natura.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/consumer-goods

Grand View Research has segmented the global hair care market on the basis of type and product:

Hair Care Type Outlook (Revenue, USD Billion, 2014 - 2025)

·         Product

·         Services

Hair Care Product Outlook (Revenue, USD Billion, 2014 - 2025)

·         Shampoo

·         Hair Color

·         Conditioner

·         Hair Styling Product

·         Hair Oil

Hair Care Regional Outlook (Revenue, USD Billion, 2014 - 2025)

·         U.S.

·         UK

·         India

·         Brazil

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-hair-care-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: https://www.grandviewresearch.com/

Movies and Entertainment Market is estimated to reach USD 114.93 billion by 2025 : Grand View Research, Inc.

Global movies & entertainment market is estimated to reach USD 114.93 billion by 2025, according to a new report by Grand View Research, Inc. Introduction to newer marketing and distribution platforms such as IPTV, digital newspapers, DTH, digital cable, and online sales of music & movies is anticipated to boost industry progress.

Decline in revenue growth in mature markets such as the U.S. and few European countries is witnessed. Major players have adopted strategies like regional expansion and distribution partnerships for expansion to untapped markets. These players have shifted their focus on the production of regional content to establish a strong connection with the audience in these markets.

Big studios are witnessed to adopt enhanced marketing strategies that use advanced digital technology for communication. Investment in promotional activates has increased drastically. Introduction of improved promotional channels is expected to positively influence revenue growth.

Rapid increase in streaming of music has created new opportunities for players to expand their business. Reduction in piracy rates due to the emergence of online streaming service providers is anticipated to prevent loss incurred by artists and producers.

The market has a low competitive rivalry due to the presence of a broad range of audience with different tastes. However, players need to compete to gain large share revenue by attracting more audience. Key players concentrate on establishing a strong connection with the audience through promotional events, consumer goods, and television shows.

Lucrative growth in Asia Pacific countries such as China, South Korea, and India is projected. This is due to the presence of higher young population, rapid adoption of digital technology, and increased disposable income of families in these countries.

Full research report on movies & entertainment market analysis: https://www.grandviewresearch.com/industry-analysis/movies-entertainment-market

Further key findings from the study suggest:

·         Movies dominated the market with 56.1 % share revenue in 2016.

·         Innovation in the production of movies through advanced graphics techniques contributes to lucrative growth.

·         Release of 3D motion pictures with sound & visual effects giving users the experience of virtual reality is anticipated to positively influence revenue growth.

·         Music & video are poised with fastest growth rate owing to the rapid adoption of online streaming by the audience.

·         Emergence of online streaming service providers reflects decline in piracy rates in developed regions.

·         Influence of Hollywood on other regional cinemas is expected to drive progress in other countries.

·         Efforts to meet higher quality standards and expectations of the audience is attributive to this progress.

·         Dominance of Hollywood in the global market is a major factor that contributes to the largest revenue share of North America in 2016.

·         However, close competition to Hollywood from emerging markets such as China and India is projected to drive growth for APAC region.

·         Key players operating in this industry include CBS Corporation and CBS Broadcasting Inc., Sony Corporation, Disney, Time Warner, 21st Century Fox, Viacom Inc., Comcast (NBCUNIVERSAL MEDIA, LLC. & DreamWorks Animation LLC.).

·         Major players focus on the development of regional content to grab the untapped markets.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/consumer-goods

Grand View Research has segmented global movies & entertainment market on the basis of product and region:

Movies & Entertainment Product Outlook (Revenue, USD Million, 2013 - 2024)

·         Movies

·         Music & Videos

Movies & Entertainment Regional Outlook (Revenue, USD Million, 2013 - 2024)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    UK

·         Asia Pacific

o    China

o    Japan

·         Latin America

o    Brazil

·         MEA

o    South Africa

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-movies-entertainment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: https://www.grandviewresearch.com/

Head and Neck Cancer Drugs size is expected to be valued at USD 1.41 billion by 2022 : Grand View Research, Inc.,

The global head and neck cancer drugs market size is expected to be valued at USD 1.41 billion by 2022, as per a new report by Grand View Research, Inc., registering a CAGR of 9.4% during the forecast period. The market is expected to be collectively driven by development of innovative and cost-effective treatments, numerous side effects related to radiation therapy and chemotherapy, increased healthcare expenditure, and better government initiatives.

As most patients suffering from head and neck cancer are diagnosed at an advanced stage, their management is often done with a multidisciplinary approach involving surgery, radiation therapy, chemotherapy, and immunotherapy in the head and neck cancer therapeutics market. Major challenges faced by this patient population are morbidity issues and poor quality of life owing to the incapacitating effects of standard of care treatment paradigms. Anemia, diarrhea, nausea, vomiting, joint pain, and osteoporosis are some of the main side effects resulting from head and neck cancer treatments.

Based on recent clinical results, immunotherapies have gained traction as a precision medicine initiative for the management of head and neck cancer. Increased immunity and immune modulation research in cancer offers new vulnerabilities that may be pharmacologically exploitable. Immunotherapy drugs such as PD inhibitors, Opdivo, and Keytruda have shown superior safety and efficacy profile in treatment of head and neck cancer. Expansion of immunotherapies will continue moving toward rational combinations with other first line or adjuvant therapies for effective treatment of metastatic or recurrent head and neck cancer. EGFR and microtubule inhibitor therapeutic classes are witnessing a fundamental shift from biologics to biosimilars.

Full research report on keyword analysis:
https://www.grandviewresearch.com/industry-analysis/head-neck-cancer-drugs-therapeutics-market

Further key findings from the report suggest:

·         Market growth will be driven by rising number of patients, increasing adoption of immunotherapeutic drugs, and launch of new drug delivery approaches to improve overall survival rates

·         Among EU5, Germany captured the top position in the global head and neck cancer therapeutics market, whereas by 2022, Spain is expected to lead the market. U.S. is expected to witness the fastest growth over the forecast period

·         Immune checkpoint inhibitors such as Opdivo and Keytruda are gaining traction and will continue to do so through forecast period, capturing more than 60.0% of the market in 2022

·         PD inhibitors will capture market share from microtubule inhibitors and EGFR inhibitors but will help expand overall franchise revenue

·         Newer immunotherapies directed against PD-1 ligands and PD-L1 proteins have shown to be more effective with superior safety profile

·         Late stage pipeline products include checkpoint inhibitors such as Imfinzi and Bavencio

·         Key players operating in this industry include Bristol-Myers Squibb, Merck, Eli Lilly, and Sanofi.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global head and neck cancer drugs market based on therapeutic class and region:

Head and Neck Cancer Drugs Therapeutic Class Outlook (Revenue, USD Million, 2016 - 2022)

·         PD Inhibitors

·         EGFR Inhibitors

·         Microtubule Inhibitors

Head and Neck Cancer Drugs Regional Outlook (Revenue, USD Million, 2016 - 2022)

·         U.S.

·         U.K.

·         France

·         Germany

·         Italy

·         Spain

·         Japan

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-head-neck-cancer-drugs-therapeutics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com